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ABSTRACT 
 
CORRELATION OF MALONDIALDEHID (MDA) LEVEL ALTERATION AS LIVER 
PREDICTOR AND ENZYME AS PARAMETER OF ADVERSE DRUG EVENTS OF 
DRUG INDUCED LIVER INJURY (DILI) IN EPILEPTIC PATIENTS WITH 
VALPROATE MONO THERAPY 
 
Martianus Perangin angin, S.Farm.,Apt 
 
Background: Epilepsy is brain abnormality that characterized with tendency to cause 
epileptic seizure continually, neurobiology, cognitive, psychology, and social consequences. 
Antiepileptic drug (AED) is main therapy for epilepsy management. The aim of epilepsy 
therapy with AED is to prevent the next seizure attack with minimal adverse effects. Valproate 
acid is antiepileptic drug that has broad spectrum and can be used to all types of epilepsy, 
especially in idiopathic general epilepsy, despite of its successful results, it has been reported 
that one of its adverse effect is to cause liver damage, which characterized with elevation of 
liver enzyme.  
 
Objective: The aim of this study is to analyze the correlation of MDA level elevation as 
predictor and abnormality of liver enzyme value. Alanine Aminotransferase (ALT) and 
Alkaline Phosphatase (ALP) are as parameters of adverse effect events of Drugs Induced 
Liver Injury (DILI) in epileptic patients with monotherapy of valproate.  
 
Methods: The study was observational prospective. The study has been approved by the 
Ethics Committee of Dr Soetomo Teaching Hospital. There are 44 subjects study who fulfilled 
inclusion criteria. Effectiveness of VPA use data was decrease of seizure intensity and 
duration that attended from patient medical record. MDA level measurement used 
Competitive-ELISA (Enzyme-linked Immunosorbent Assay) and ALP & AST level 
measurement used Spectrofotometry in laboratory at Universitas Airlangga Surabaya. 
 
Result: From all of three parameters that tested, correlation of MDA to ALP, ALT and 
ALT/ALP ratio, it can be concluded statistically that there is no correlation between elevation 
of MDA level to ALP with p value (p>0,05). However there is negative correlation between 
elevation of MDA level to ALT/ALP ratio with p value (p<0,05). This study also resulted that 
duration of VPA monotherapy affects to seizure intensity and duration before and after 
therapy with (p=0.000) and (p=0.000) consecutively. 
 
Conclusion: According to the study results, it can be concluded that no correlation between   
elevation of MDA level is predictor of liver enzymes of ALP and ALT as parameters of 
adverse drug event of Drug Induced Liver Injury (DILI)  to epileptic patients with VPA mono 
therapy. 
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